Eli Lilly Settles Lawsuits Alleging Heart Attack & Stroke from Testosterone Products

Testosterone Heart Attack/Stroke Lawsuits

On December 21, 2017, parties in the lawsuits against Eli Lilly alleging heart attacks and strokes from testosterone products informed Illinois Federal MDL judge, Matthew F. Kennelly, that they had reached a global settlement in all cases filed against the pharmaceutical company in the multidistrict litigation over testosterone replacement therapy products. The deal comes just before…

Read More

Another Jury Finds AbbVie Misrepresented Risks of AndroGel & Awards $140 Million Verdict in Testosterone Heart Attack Lawsuit

Testosterone Heart Attack/Stroke Lawsuits

On October 5, 2017, a Chicago jury ordered AbbVie, Inc. to pay more than $140 million to a Tennessee man, Jeffrey Konrad, who alleged that the Company misrepresented the risks of his testosterone replacement drug, AndroGel prescribed for Low-T, causing him to suffer a heart attack. This case is one of many in the testosterone…

Read More

$150 Million Punitive Damages Verdict in Testosterone Heart Attack Lawsuit for False Marketing

Testosterone Heart Attack/Stroke Lawsuits

On July 24, 2017, a Chicago jury found in favor of claimant Jesse Mitchell in the second, much-anticipated AndroGel bellwether trial that started on July 5 in the testosterone replacement therapy (TRT) multidistrict litigation in the U.S. District Court for the Northern District of Illinois (Jesse Mitchell, et al. v. AbbVie, Inc., No. 14-9178, N.D….

Read More